In a 740,000-square-foot production facility here, Samsung machines are humming day and night to churn out an unlikely product for the world’s largest maker of smartphones: cancer drugs developed by Bristol-Myers Squibb Co. The Samsung Group's $27.4 billion investment over the past four years in production plants and research laboratories like this..

Click here to read full article